About: http://webisa.webdatacommons.org/397580659

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Alternatively, there is a question as to whether manufacturers may seek retroactive payments from Newly Eligible Providers for any orphan drugs purchased at 340B prices.
http://www.w3.org/ns/prov#wasQuotedFrom	jdsupra.com